In contrast, urinary K+ retention and hyperkalemia are hallmarks of patients with pseudohypoaldosteronism type II (PHAII) who have hyperactivation of NCC (18, 19). The gene discussed is SLC12A3; the disease is pseudohypoaldosteronism type 2.